News | March 03, 2023
Pharmapack 2023 a pivotal moment for sustainability in drug delivery and packaging
Nearly 5000 executives and more than 350 exhibitors turned out at the largest post-pandemic pharma packaging event
Nearly 5000 executives and more than 350 exhibitors turned out at the largest post-pandemic pharma packaging event
The British-Swedish pharma major certainly has a strong competitive edge for BTC treatment in the country
The marketing authorisations for three generic drugs signifying advances in cancer treatment will considerably benefit thousands of patients by improving access, ensuring affordability
The new company will utilize Teijin's drug discovery research technologies, facilities, equipment and personnel.
Label expansion for CIBINQO provides new systemic oral option for adolescents (12 to <18 years) with moderate-to-severe atopic dermatitis
The Innovation Explorer database of GlobalData’s Disruptor Intelligence Center highlights the key company collaborations in pharma to advance AI-powered drug repurposing techniques.
This clearance allows the company to initiate a clinical trial for patients with an ileal pouch-anal anastomosis
Standalone Q3 FY23 revenue stood at Rs. 626.5 crore as against Rs. 594.8 crore, a growth of 5% YoY
The supplemental New Drug Application is based on results from the landmark EMPA-KIDNEY phase III trial
Valentas and Arnipin are indicated to reduce repeated hospitalization and the risk of cardiovascular death among adult patients with chronic mild to moderate heart failure
Subscribe To Our Newsletter & Stay Updated
